A Phase 2 GFR Measuring Study of RTA 402 in CKD Patients With Type 2 Diabetes Mellitus
Phase 2
- Conditions
- CKD patients with type 2 diabetes
- Registration Number
- JPRN-jRCT2080221750
- Lead Sponsor
- Kyowa Hakko Kirin Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
CKD patients with type 2 diabetes mellitus
-Patients whose eGFR levels are eligible for this study
-Patients being treated with stable dose of ACE inhibitors and/or ARB etc.
Exclusion Criteria
-Patients with Type 1 diabetes
-Patients with known non-diabetic renal disease
-Patients with a history of renal transplantation
-Patients with mean SBP > 160 mmHg or mean DBP > 90 mmHg
-Patients with HbA1C > 10%
-Patients with cardiovascular disease specified in the study protocol
-Patients for whom Inulead(R) injection is contraindicated etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method